Experimental studies on lignans and cancer.

Area of Science:

• Nutritional biochemistry
• Cancer research
• Microbiology

Background:

• Mammalian lignans are derived from plant precursors like secoisolariciresinol diglycoside (SDG) through colonic bacterial metabolism.
• Flaxseed is identified as the richest dietary source of SDG, making it a key model for lignan research.
• Lignans are recognized for their potential health benefits, including anti-cancer effects.

Purpose of the Study:

• To review experimental evidence on the anti-cancer effects of flaxseed and its lignans, particularly SDG.
• To consolidate information on the clinical applicability of lignans.
• To explore dietary sources, bioavailability, and safety of lignans.

Main Methods:

• Literature review of experimental studies in animals and humans.
• Analysis of research on flaxseed as a model for SDG.
• Examination of studies on lignan food sources, absorption, and safety.

Main Results:

• Experimental studies in animals and humans demonstrate anti-cancer effects associated with flaxseed and its lignans.
• Flaxseed is confirmed as a rich source of SDG, a key precursor for mammalian lignans.
• Data on lignan bioavailability and safety support their potential clinical use.

Conclusions:

• Flaxseed lignans, especially SDG, show promising anti-cancer effects supported by preclinical and clinical research.
• Understanding the sources, bioavailability, and safety of lignans is crucial for their therapeutic application.
• Further research into lignans could lead to novel dietary strategies for cancer prevention and treatment.